
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The Molecular and Clinical Impact of Atorvastatin Exposure on Paclitaxel Neurotoxicity in Sensory Neurons and Cancer Patients - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="3D96DF5D8095420300DF5D001CD624A7.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955935/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Basic &amp; Clinical Pharmacology &amp; Toxicology">
<meta name="citation_title" content="The Molecular and Clinical Impact of Atorvastatin Exposure on Paclitaxel Neurotoxicity in Sensory Neurons and Cancer Patients">
<meta name="citation_author" content="Emma Simonsen">
<meta name="citation_author_institution" content="Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark">
<meta name="citation_author" content="Christina Mortensen">
<meta name="citation_author_institution" content="Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark">
<meta name="citation_author" content="Cathrine Lundgaard Riis">
<meta name="citation_author_institution" content="Department of Oncology, Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark">
<meta name="citation_author" content="Karina Dahl Steffensen">
<meta name="citation_author_institution" content="Department of Oncology, Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark">
<meta name="citation_author_institution" content="Department of Regional Health Research, University of Southern Denmark, Odense, Denmark">
<meta name="citation_author" content="Morten Olesen">
<meta name="citation_author_institution" content="Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark">
<meta name="citation_author" content="Martin Thomsen Ernst">
<meta name="citation_author_institution" content="Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark">
<meta name="citation_author" content="Tore Bjerregaard Stage">
<meta name="citation_author_institution" content="Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark">
<meta name="citation_author_institution" content="Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark">
<meta name="citation_author" content="Anton Pottegård">
<meta name="citation_author_institution" content="Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark">
<meta name="citation_publication_date" content="2025 Mar 27">
<meta name="citation_volume" content="136">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70022">
<meta name="citation_doi" content="10.1111/bcpt.70022">
<meta name="citation_pmid" content="40143680">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955935/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955935/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955935/pdf/BCPT-136-0.pdf">
<meta name="description" content="Recent evidence suggests that atorvastatin exacerbates paclitaxel neurotoxicity via P‐glycoprotein inhibition. We used a translational approach to investigate if atorvastatin or simvastatin exacerbates (i) paclitaxel neurotoxicity in human sensory ...">
<meta name="og:title" content="The Molecular and Clinical Impact of Atorvastatin Exposure on Paclitaxel Neurotoxicity in Sensory Neurons and Cancer Patients">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Recent evidence suggests that atorvastatin exacerbates paclitaxel neurotoxicity via P‐glycoprotein inhibition. We used a translational approach to investigate if atorvastatin or simvastatin exacerbates (i) paclitaxel neurotoxicity in human sensory ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955935/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11955935">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/bcpt.70022"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/BCPT-136-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11955935%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11955935/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11955935/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955935/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/bcpt.70022" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Basic Clin Pharmacol Toxicol</button></div>. 2025 Mar 27;136(5):e70022. doi: <a href="https://doi.org/10.1111/bcpt.70022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/bcpt.70022</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The Molecular and Clinical Impact of Atorvastatin Exposure on Paclitaxel Neurotoxicity in Sensory Neurons and Cancer Patients</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Simonsen%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Emma Simonsen</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Emma Simonsen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Simonsen%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Emma Simonsen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mortensen%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Christina Mortensen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Christina Mortensen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mortensen%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christina Mortensen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Riis%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Cathrine Lundgaard Riis</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Cathrine Lundgaard Riis</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Oncology, Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Riis%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cathrine Lundgaard Riis</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Steffensen%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Karina Dahl Steffensen</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Karina Dahl Steffensen</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Oncology, Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Regional Health Research, University of Southern Denmark, Odense, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Steffensen%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Karina Dahl Steffensen</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olesen%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Morten Olesen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Morten Olesen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olesen%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Morten Olesen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ernst%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Martin Thomsen Ernst</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Martin Thomsen Ernst</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ernst%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Martin Thomsen Ernst</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stage%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Tore Bjerregaard Stage</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Tore Bjerregaard Stage</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stage%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tore Bjerregaard Stage</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Potteg%C3%A5rd%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Anton Pottegård</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Anton Pottegård</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Potteg%C3%A5rd%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anton Pottegård</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="bcpt70022-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark</div>
<div id="bcpt70022-aff-0002">
<sup>
<sup>2</sup>
</sup>Department of Oncology, Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark</div>
<div id="bcpt70022-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Regional Health Research, University of Southern Denmark, Odense, Denmark</div>
<div id="bcpt70022-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Anton Pottegård (<span>apottegaard@health.sdu.dk</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Mar 5; Received 2024 Aug 14; Accepted 2025 Mar 6; Issue date 2025 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Basic &amp; Clinical Pharmacology &amp; Toxicology</em> published by John Wiley &amp; Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11955935  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40143680/" class="usa-link">40143680</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Recent evidence suggests that atorvastatin exacerbates paclitaxel neurotoxicity via P‐glycoprotein inhibition. We used a translational approach to investigate if atorvastatin or simvastatin exacerbates (i) paclitaxel neurotoxicity in human sensory neurons and (ii) paclitaxel‐induced peripheral neuropathy (PIPN) in cancer patients. Paclitaxel neurotoxicity was assessed by quantifying neuronal networks of human induced pluripotent stem cell‐derived sensory neurons (iPSC‐SNs) with and without atorvastatin or simvastatin exposure. We estimated the odds ratio (OR) of early paclitaxel discontinuation due to PIPN in a nationwide cohort of paclitaxel‐treated women (2014–2018), comparing atorvastatin users to simvastatin users and nonusers of statins. Only the highest concentration of atorvastatin (100 nM) significantly exacerbated paclitaxel neurotoxicity in iPSC‐SNs (<em>p</em> &lt; 0.05). Among 576 paclitaxel‐treated women, atorvastatin use was not significantly associated with early paclitaxel discontinuation due to PIPN, with adjusted ORs of 0.80 [95% confidence interval (CI) 0.34–1.88] compared with simvastatin, and 1.24 [95% CI 0.44–3.53] compared with nonuse. Supplementary analyses showed varying but statistically nonsignificant results. Our in vitro findings suggest that atorvastatin, not simvastatin, significantly worsens paclitaxel neurotoxicity. However, no link was found between atorvastatin use and early paclitaxel discontinuation due to PIPN. Larger, well‐designed studies are required to clarify the discrepancy between in vitro and clinical data and the inconsistencies with previous clinical evidence.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> chemotherapy, neurotoxicity, paclitaxel, peripheral neuropathy, sensory neurons, statins, translational research</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<section class="bt xbox font-sm" id="bcpt70022-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e0/11955935/8262ee74ce5d/BCPT-136-0-g002.jpg" loading="lazy" id="jats-graphic-1" height="196" width="250" alt="graphic file with name BCPT-136-0-g002.jpg"></p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="bcpt70022-blkfxd-0002"><h2 class="obj_head">Summary.</h2>
<ul id="bcpt70022-list-0001" class="list" style="list-style-type:disc">
<li id="bcpt70022-li-0001"><p>Paclitaxel frequently causes peripheral sensory neuropathy, resulting in neuropathic pain and sensory disturbances in patients receiving treatment for cancer.</p></li>
<li id="bcpt70022-li-0002"><p>Our limited understanding of pathogenesis and risk factors of paclitaxel‐induced peripheral neuropathy (PIPN) impedes the development of preventative and therapeutic strategies.</p></li>
<li id="bcpt70022-li-0003"><p>Recent evidence suggests that atorvastatin exacerbates paclitaxel neurotoxicity via P‐glycoprotein inhibition.</p></li>
<li id="bcpt70022-li-0004"><p>In our study, only the highest concentration of atorvastatin exacerbated paclitaxel neurotoxicity in vitro, but we found no association between atorvastatin use and early paclitaxel discontinuation due to PIPN.</p></li>
<li id="bcpt70022-li-0005"><p>Future studies using objective measures of different PIPN phenotypes are required to clarify this discordance between in vitro and clinical data, as well as the inconsistencies with previous evidence.</p></li>
</ul></section><section id="bcpt70022-sec-0003"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>A common adverse effect of many cancer drugs, especially taxanes [<a href="#bcpt70022-bib-0001" class="usa-link" aria-describedby="bcpt70022-bib-0001">1</a>], is chemotherapy‐induced peripheral neuropathy (CIPN) [<a href="#bcpt70022-bib-0002" class="usa-link" aria-describedby="bcpt70022-bib-0002">2</a>]. CIPN is primarily caused by damage to sensory neurons of the peripheral nervous system, and its clinical manifestations include neuropathic pain and sensory disturbances, such as numbness and paraesthesia in hands and feet. Although paclitaxel is essential in the treatment of solid tumours like breast and ovarian cancers, it leads to CIPN in a large proportion of patients [<a href="#bcpt70022-bib-0003" class="usa-link" aria-describedby="bcpt70022-bib-0003">3</a>, <a href="#bcpt70022-bib-0004" class="usa-link" aria-describedby="bcpt70022-bib-0004">4</a>, <a href="#bcpt70022-bib-0005" class="usa-link" aria-describedby="bcpt70022-bib-0005">5</a>]. Because CIPN cannot be treated effectively with currently available medications [<a href="#bcpt70022-bib-0005" class="usa-link" aria-describedby="bcpt70022-bib-0005">5</a>], it can develop into a chronic condition [<a href="#bcpt70022-bib-0006" class="usa-link" aria-describedby="bcpt70022-bib-0006">6</a>] with significant impact on quality of life [<a href="#bcpt70022-bib-0007" class="usa-link" aria-describedby="bcpt70022-bib-0007">7</a>]. Consequently, severe CIPN is managed by treatment adjustments, such as dose reduction, treatment delay or treatment discontinuation, which can reduce therapeutic efficacy [<a href="#bcpt70022-bib-0008" class="usa-link" aria-describedby="bcpt70022-bib-0008">8</a>] and influence the prognosis of cancer patients.</p>
<p>An improved understanding of the pathogenesis and risk factors of paclitaxel‐induced peripheral neuropathy (PIPN) is essential for the development of preventative and therapeutic strategies. Commonly prescribed drugs such as statins and beta blockers have been associated with an increased risk of PIPN [<a href="#bcpt70022-bib-0009" class="usa-link" aria-describedby="bcpt70022-bib-0009">9</a>, <a href="#bcpt70022-bib-0010" class="usa-link" aria-describedby="bcpt70022-bib-0010">10</a>]. Importantly, paclitaxel is a substrate for the efflux transporter P‐glycoprotein (P‐gp), which is expressed in human dorsal root ganglia [<a href="#bcpt70022-bib-0010" class="usa-link" aria-describedby="bcpt70022-bib-0010">10</a>]. P‐gp is responsible for limiting the accumulation of toxic substances within cells and as such, concomitantly administered P‐gp inhibitors may exacerbate paclitaxel neurotoxicity [<a href="#bcpt70022-bib-0010" class="usa-link" aria-describedby="bcpt70022-bib-0010">10</a>]. Notably, the mRNA expression of P‐gp has been observed in the context of neuronal exposure to substances like paclitaxel, suggesting its role in drug transport [<a href="#bcpt70022-bib-0011" class="usa-link" aria-describedby="bcpt70022-bib-0011">11</a>]. A potential inhibitor of P‐gp is atorvastatin [<a href="#bcpt70022-bib-0010" class="usa-link" aria-describedby="bcpt70022-bib-0010">10</a>]. In a clinical setting, users of atorvastatin have been found to be at greater risk of dose‐adjustments of paclitaxel treatment due to sensory neuropathy compared with users of simvastatin [<a href="#bcpt70022-bib-0010" class="usa-link" aria-describedby="bcpt70022-bib-0010">10</a>]. However, before clinicians can be advised to switch paclitaxel‐treated patients from atorvastatin to another statin, further clinical confirmation is required. Here, a translational approach was used to determine if atorvastatin exacerbates paclitaxel neurotoxicity in a human cell model and in patients with gynaecologic cancer or breast cancer.</p></section><section id="bcpt70022-sec-0004"><h2 class="pmc_sec_title">2. Methods and Materials</h2>
<p>We (i) determined if paclitaxel neurotoxicity is exacerbated by atorvastatin or simvastatin in iPSC‐derived sensory neurons (iPSC‐SNs) and (ii) evaluated the risk of paclitaxel treatment adjustment due to PIPN among atorvastatin users, simvastatin users and nonusers of statins by accessing registry data on paclitaxel use and manually reviewing medical records. The study was conducted in accordance with the Basic &amp; Clinical Pharmacology &amp; Toxicology policy for experimental and clinical studies [<a href="#bcpt70022-bib-0012" class="usa-link" aria-describedby="bcpt70022-bib-0012">12</a>].</p>
<section id="bcpt70022-sec-0005"><h3 class="pmc_sec_title">Cell Model</h3></section><section id="bcpt70022-sec-0006"><h3 class="pmc_sec_title">2.1. Sensory Neuron Differentiation</h3>
<p>Sensory neurons were differentiated from a healthy iPSC donor (A18945, ThermoFisher, Roskilde, Denmark, hpscreg.eu/cell‐line/TMOi001‐A), as described in detail elsewhere [<a href="#bcpt70022-bib-0013" class="usa-link" aria-describedby="bcpt70022-bib-0013">13</a>]. Briefly, iPSCs were maintained in mTeSR1 medium (85850, StemCell Technologies, Vancouver, <span class="font-variant-small-caps">bc</span>, Canada) on Matrigel (354277, Corning, NY, USA) with daily medium change. Upon 70%–80% confluency, iPSCs were clump‐passaged using Accutase (00455556, ThermoFisher). The differentiation was performed using 5 small molecule inhibitors for 12 days followed by maturation with four neurotrophic growth factors and ascorbic acid (A4403, Sigma‐Aldrich, Saint Louis, MO, USA) for 23–33 days. The small molecule inhibitors LDN193189 (S7507), SB431542 (S1067), CHIR99021 (S1263), SU5402 (S7667) and DAPT (S2215) were purchased from Selleck Chemicals (Houston, TX, USA). The neurotrophic growth factors NGF‐β (450‐01), BDNF (450‐02), GDNF (450‐10) and NT‐3 (450‐03) were obtained from Peprotech (Cranbury, NJ, USA). On day 12, immature sensory neurons were seeded as single cells at a density of 150 000 cells/cm<sup>2</sup> on culture plates coated with poly‐L‐ornithine hydrobromide (20 μg/mL, P3655, Sigma‐Aldrich), laminin (10 μg/mL, 23 017 015, ThermoFisher) and fibronectin (2 μg/mL, F1141, Sigma‐Aldrich). On day 14, nonneuronal cells were removed using Mitomycin‐C (1 μg/mL, M4287, Sigma‐Aldrich) for 2 h. On day 16, all medium was replaced and afterwards, 50% of the medium was changed every 3–4 days. The mature sensory neurons were used for experiments between days 35 and 45.</p></section><section id="bcpt70022-sec-0007"><h3 class="pmc_sec_title">2.2. Compound Preparations and Considerations</h3>
<p>Paclitaxel (T7402, Sigma‐Aldrich, Søborg, Denmark), atorvastatin (PZ0001, Sigma‐Aldrich) and simvastatin (S6196, Sigma‐Aldrich) were dissolved and serially diluted in dimethyl sulfoxide (DMSO, D8418, Sigma‐Aldrich). The final concentration of DMSO was maintained at 0.2% for all conditions, and the same concentration of DMSO was included as a vehicle control. The concentrations of paclitaxel and statins were ensured to be clinically relevant. We selected the concentrations based on their maximum observed plasma concentration after commonly used dosing regimens, while accounting for their high plasma protein binding and interindividual variability in clinical pharmacokinetic profiles (Table <a href="#bcpt70022-supitem-0001" class="usa-link">S1</a>) [<a href="#bcpt70022-bib-0014" class="usa-link" aria-describedby="bcpt70022-bib-0014">14</a>, <a href="#bcpt70022-bib-0015" class="usa-link" aria-describedby="bcpt70022-bib-0015">15</a>]. iPSC‐SNs seeded in 24‐well plates were treated with 0.1‐, 1.0‐ and 10‐μM paclitaxel. We used atorvastatin concentrations at 10 and 100 nM and simvastatin concentrations at 5 and 50 nM. iPSC‐SNs were pretreated with statins for 1 h to allow binding to drug transporters. After pretreatment, iPSC‐SNs were exposed to vehicle, or paclitaxel with and without concomitant exposure to statins for 48 h.</p></section><section id="bcpt70022-sec-0008"><h3 class="pmc_sec_title">2.3. Immunolabelling and Neurotoxicity Assessment</h3>
<p>Following exposure to paclitaxel and statins, iPSC‐SNs were fixed with 4% paraformaldehyde for 10 min. Specifically, 200 μL of medium was removed from each well and 16% paraformaldehyde (28906, ThermoFisher) was diluted 1:4 into the medium to minimize cell detachment. After two washing steps with phosphate buffered saline containing Ca<sup>2+</sup> and Mg<sup>2+</sup> (PBS+, D8662, Sigma‐Aldrich), iPSC‐SNs were permeabilized with 0.25% Triton X‐100 for 15 min. Unspecific binding was subsequently blocked using 1% bovine serum albumin (A9418, Sigma‐Aldrich) for 1 h. iPSC‐SNs were labelled with peripherin (1:200, SC‐377093, Santa Cruz) overnight at 4°C. The following day, iPSC‐SNs were labelled with Alexa Fluor 488‐conjugated anti‐mouse (1:400, A11001, ThermoFisher) for 1 h at room temperature. Importantly, all medium was only removed at the final washing step after fixation and before addition of primary and secondary antibodies. For all other steps, 10% of the washing or blocking buffer remained in each well. Labelled cells were stored in PBS+ until image acquisition. A template was created in CellReporterXpress (Molecular Devices, San Jose, CA, USA) to systematically acquire three images per well for all plates. Images were acquired using ImageXpress Pico Automated Imaging System with the 10× objective (Molecular Devices, San Jose, CA, USA). Several in vitro studies have demonstrated that axons, rather than cell bodies, are sensitive to paclitaxel toxicity [<a href="#bcpt70022-bib-0016" class="usa-link" aria-describedby="bcpt70022-bib-0016">16</a>]. As such, we assessed neurotoxicity by measuring the number of axons emanating from each ganglion using Sholl analysis (ImageJ software 2.0.0). The analysis was blinded to the person performing Sholl analysis to ensure no bias. All images were converted to 8‐bit, and a threshold of 38 was applied. The centre of the ganglion was defined using the straight‐line tool, and Sholl analysis was performed with an appropriate end‐radius for all ganglia in each image. The end‐radius was adjusted manually according to the size of the ganglia. Figure <a href="#bcpt70022-supitem-0001" class="usa-link">S1</a> shows threshold adjustment and Sholl analysis. The experiment was repeated in iPSC‐SNs from three individual differentiations.</p></section><section id="bcpt70022-sec-0009"><h3 class="pmc_sec_title">Health Registers and Medical Records</h3></section><section id="bcpt70022-sec-0010"><h3 class="pmc_sec_title">2.4. Study Cohort</h3>
<p>To ensure a high retrieval rate of medical records and comparability between atorvastatin and simvastatin users, we restricted the study period to 1 January 2014 to 31 December 2018, a period during which atorvastatin and simvastatin were used equally in Denmark [<a href="#bcpt70022-bib-0017" class="usa-link" aria-describedby="bcpt70022-bib-0017">17</a>]. During this period, we identified all women with at least one paclitaxel procedure code recorded in the Danish National Patient Registry [<a href="#bcpt70022-bib-0018" class="usa-link" aria-describedby="bcpt70022-bib-0018">18</a>]. The population was further limited to people with a valid civil registration number in the Civil Registration System [<a href="#bcpt70022-bib-0019" class="usa-link" aria-describedby="bcpt70022-bib-0019">19</a>]. Finally, we restricted to women diagnosed with gynaecologic cancer (International Classification of Diseases, 10<sup>th</sup> revision [ICD10], C53‐57) or breast cancer (C50) within 1 year prior to starting paclitaxel treatment (Table <a href="#bcpt70022-supitem-0001" class="usa-link">S2</a>). For this cohort, we identified all filled statin prescriptions, defined by Anatomical Therapeutic Chemical (ATC) code C10AA*, from the Danish National Prescription Registry [<a href="#bcpt70022-bib-0020" class="usa-link" aria-describedby="bcpt70022-bib-0020">20</a>] and identified women who, prior to starting paclitaxel treatment, had redeemed atorvastatin, simvastatin or neither of these drugs. Statin users were classified as such by having redeemed a prescription on either atorvastatin or simvastatin within 120 days before starting paclitaxel treatment. In Denmark, when medical treatment is stable, patients normally receive a 3‐month supply of medication, which typically consists of 100 tablets for medication taken once daily [<a href="#bcpt70022-bib-0021" class="usa-link" aria-describedby="bcpt70022-bib-0021">21</a>]. And as such, we chose an exposure period of 120 days. For users of both statins, the latest exposure was used. For each atorvastatin user, we aimed to identify one simvastatin user and one nonuser, matching on age (in 5‐year bands) and hospital department. Due to data limitations, the final count of simvastatin users was 315 instead of 350.</p>
<p>The women were treated in oncology departments at 11 hospitals across all five regions of Denmark: Rigshospitalet, Herlev and Gentofte Hospital, North Zealand Hospital, Region Zealand Hospital Service, Odense University Hospital, Hospital Sønderjylland, Hospital South West Jutland, Vejle Hospital, Aarhus University Hospital, Hospital Unit West and Aalborg University Hospital.</p>
<p>The civil registration numbers linked data from health registers and data from medical records. Both patient characteristics and information on paclitaxel treatment, including treatment adjustments, were collected from medical records. The review was blinded for medication status, including the women's statin exposure status. Only notes entered by medical doctors or nurses within the study period were disclosed to the reviewer. All study data were collected and stored in REDCap [<a href="#bcpt70022-bib-0022" class="usa-link" aria-describedby="bcpt70022-bib-0022">22</a>] hosted by OPEN (Open Patient data Explorative Network).</p></section><section id="bcpt70022-sec-0011"><h3 class="pmc_sec_title">2.5. Patient Characteristics</h3>
<p>The patient characteristics collected included height, weight, cancer diagnosis, cancer stage and potential confounders such as Eastern Cooperative Oncology Group (ECOG) performance status, alcohol, smoking and neurological comorbidity. Here, ‘neurological comorbidity’ included neurological disease (e.g., multiple sclerosis and neurofibromatosis) and preexisting sensory disturbances. At baseline, sensory disturbances could be due to conditions like diabetes, infections, nerve compression syndromes or traumatic injuries. Lastly, paclitaxel dose (mg) and treatment schedule were collected.</p>
<p>Women who, at any time prior to starting paclitaxel treatment, had redeemed a prescription for a glucose‐lowering drug (defined by ATC code A10*, i.e., drugs used in diabetes) were categorized as having diabetes.</p></section><section id="bcpt70022-sec-0012"><h3 class="pmc_sec_title">2.6. Treatment Adjustment</h3>
<p>For each paclitaxel treatment adjustment (i.e., reduction and discontinuation), it was noted whether it was due to toxicity or another reason. The toxicities recorded included: PIPN, haematological toxicity and febrile neutropenia. The other reasons recorded included: poor health, allergic reaction, wishes of the patient or limited treatment response. The reason ‘poor health’ included factors such as old age, fatigue/weariness and common gastrointestinal symptoms (e.g., diarrhoea and nausea). Some adjustments were due to both toxicity and another reason.</p>
<p>Because standard paclitaxel treatment is six cycles for gynaecologic cancer patients and ≤ 12 cycles for most breast cancer patients, we did not follow patients beyond the 12<sup>th</sup> cycle. This only restricted the data capture for those breast cancer patients who had distant metastases and therefore received &gt; 12 paclitaxel treatments.</p>
<p>The composite endpoint ‘paclitaxel treatment modification’ encompassed all‐cause dose reduction and treatment discontinuation, unless a specific cause was provided. A dose reduction was defined as receiving less than standard dose (i.e., 175 mg/m<sup>2</sup> once every 3 weeks for gynaecologic cancer and 80 mg/m<sup>2</sup> once every week for breast cancer). All breast cancer patients received paclitaxel as a monotherapy administered once weekly. All gynaecologic cancer patients received paclitaxel in combination with carboplatin every 3 weeks. A treatment discontinuation was defined as termination of paclitaxel prior to completing scheduled treatment, including cessation during infusion of paclitaxel.</p></section><section id="bcpt70022-sec-0013"><h3 class="pmc_sec_title">Statistical Analysis</h3></section><section id="bcpt70022-sec-0014"><h3 class="pmc_sec_title">2.7. Cell Data</h3>
<p>Analysis of cell data was performed in R (version 4.0.2; R Statistical Foundation for Statistical Computing). Graph was created using the ggplot2 package.</p>
<p>Number of axons was calculated relative to the mean of the vehicle control for each individual differentiation. The mean of relative ratios for each condition was subsequently calculated for the three independent differentiations. Differences between relative ratios were tested for statistical significance using nonparametric Kruskal–Wallis test because the assumption of normality of observations could not be met with so few data points.</p></section><section id="bcpt70022-sec-0015"><h3 class="pmc_sec_title">2.8. Clinical Data</h3>
<p>The collected clinical data were uploaded to a server hosted by the Danish Health Data Authority, and calculations were performed using STATA 17 (Stata‐Corp, College Station, TX). To ensure data confidentiality, the number of patients below five was presented as ‘&lt; 5’.</p>
<p>We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (Cs) for the association between atorvastatin use and risk of early paclitaxel discontinuation due to PIPN, while adjusting for age, alcohol, smoking, neurological comorbidity and diabetes. We defined early discontinuation as treatment cessation before the fourth treatment cycle for gynaecologic cancer patients and before the seventh treatment cycle for breast cancer patients. As a supplementary analysis, the association was also evaluated for all recorded treatment cycles. In our primary analysis, atorvastatin users were compared with simvastatin users, and to put our primary analysis in perspective, users of atorvastatin and users of simvastatin were also compared with respect to all‐cause paclitaxel discontinuation.</p>
<p>As secondary outcomes, users of atorvastatin and users of simvastatin were compared with respect to all‐cause paclitaxel treatment modification, as well as paclitaxel treatment modification due to PIPN, haematological toxicity, poor health or allergic reaction, individually.</p></section></section><section id="bcpt70022-sec-0016"><h2 class="pmc_sec_title">3. Results</h2>
<section id="bcpt70022-sec-0017"><h3 class="pmc_sec_title">3.1. Paclitaxel Neurotoxicity in iPSC‐SNs</h3>
<p>Atorvastatin exacerbated 0.1‐, 1.0‐ and 10‐μM paclitaxel neurotoxicity at the applied concentration of 100 nM (Figure <a href="#bcpt70022-fig-0001" class="usa-link">1</a>, Figure <a href="#bcpt70022-fig-0002" class="usa-link">2</a>; <em>p</em> &lt; 0.05). Simvastatin, however, did not affect paclitaxel neurotoxicity in a statistically significant manner (Figure <a href="#bcpt70022-fig-0002" class="usa-link">2</a>). Exposure to both statins alone did not significantly increase neurotoxicity in iPSC‐SNs compared with vehicle (Figure <a href="#bcpt70022-fig-0002" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="bcpt70022-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e0/11955935/4d97654cce97/BCPT-136-0-g004.jpg" loading="lazy" id="jats-graphic-3" height="709" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70022-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Exposure to paclitaxel alone reduces the neuronal network of iPSC‐derived sensory neurons, and this effect is exacerbated by concomitant exposure to atorvastatin. Atorvastatin alone also causes minimal neurotoxicity in iPSC‐derived sensory neurons. Cells were treated with 100‐nM paclitaxel for 48 h with and without concomitant treatment with 100‐nM atorvastatin. The control was treated with vehicle (0.2% DMSO). Cells were labelled with peripherin, and images were acquired using ImageXpress Pico with the 10× objective. The end‐radius was adjusted manually according to the size of the ganglia. Representative images are shown. Scale bar represents 200 μm.</p></figcaption></figure><figure class="fig xbox font-sm" id="bcpt70022-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e0/11955935/f0642dbc4f8d/BCPT-136-0-g001.jpg" loading="lazy" id="jats-graphic-5" height="609" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70022-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Atorvastatin exacerbated paclitaxel neurotoxicity at the applied concentration of 100 nM (<em>p</em> &lt; 0.05, nonparametric Kruskal–Wallis test). Simvastatin did not significantly exacerbate paclitaxel neurotoxicity at the applied concentrations of 5 and 50 nM. Both statins alone caused no neurotoxicity in iPSC‐derived sensory neurons. The number of axons emanating from each ganglion was quantified using Sholl analysis, and three images were acquired for each condition from three independent differentiations.</p></figcaption></figure></section><section id="bcpt70022-sec-0018"><h3 class="pmc_sec_title">3.2. Study Cohort</h3>
<p>We identified 8235 women who started paclitaxel treatment within 1 year of being diagnosed with either gynaecologic cancer or breast cancer during 2014–2018. Of these, 350 women (4.3%) were classified as using atorvastatin, and 315 matched simvastatin users and 350 matched nonusers were also eligible for inclusion in the final stage with review of medical records (Figure <a href="#bcpt70022-fig-0003" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="bcpt70022-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e0/11955935/672f13ddfc88/BCPT-136-0-g003.jpg" loading="lazy" id="jats-graphic-7" height="439" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/bcpt70022-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CONSORT diagram. *Patients diagnosed with either gynaecologic cancer or breast cancer.</p></figcaption></figure><p>A total of 846 out of 1015 women were included in the review process due to exclusion at hospital‐level; Hospital Unit West declined to participate in the study, and North Zealand Hospital was unable to retrieve medical records locally. During the review process, 270 women were excluded from the study due to the following reasons: received paclitaxel before 2014, received other chemotherapy less than 5 years before starting paclitaxel treatment, missing data for scheduled treatment, not meeting the inclusion criteria, including first‐line treatment with paclitaxel and irretrievable medical record (Figure <a href="#bcpt70022-fig-0003" class="usa-link">3</a>). All women diagnosed with cervical cancer were excluded because they received paclitaxel as minimum second‐line treatment. The final cohort available for analysis included 200 atorvastatin users, 183 simvastatin users and 193 nonusers (Figure <a href="#bcpt70022-fig-0003" class="usa-link">3</a>, Table <a href="#bcpt70022-tbl-0001" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="bcpt70022-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>The cohort's baseline characteristics, mostly based on medical records; use of anti‐diabetic drugs is register‐based.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Atorvastatin (<em>n</em> = 200)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Simvastatin (<em>n</em> = 183)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Nonuse (<em>n</em> = 193)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age (years, median, IQR)</td>
<td align="center" valign="top" rowspan="1" colspan="1">65 (58–71)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67 (61–72)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67 (58–72)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Body surface area (m<sup>2</sup>, median, IQR)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.83 (1.70–1.97)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.83 (1.72–1.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.75 (1.64–1.92)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">ECOG performance status, (%)</td>
<td align="center" colspan="3" valign="top" rowspan="1"></td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">155 (78%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">146 (80%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">145 (75%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (18%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (13%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (19%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2+</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (4.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (3.1%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cancer diagnosis, (%)</td>
<td align="center" colspan="3" valign="top" rowspan="1"></td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Breast cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">131 (66%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">118 (64%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">131 (68%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Uterine cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 (15%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (11%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (8.3%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (18%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">43 (23%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (23%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cancer of other and unspecified female genitals</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> &lt; 5</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> &lt; 5</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> &lt; 5</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Stage breast cancer, (%)</td>
<td align="center" colspan="3" valign="top" rowspan="1"></td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Local</td>
<td align="center" valign="top" rowspan="1" colspan="1">68 (34%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">57 (31%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">62 (32%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Locally advanced</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 (27%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49 (27%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">59 (31%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Metastatic</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> &lt; 5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.6%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Stage gynaecologic cancer (FIGO), (%)</td>
<td align="center" colspan="3" valign="top" rowspan="1"></td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">I</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (3.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> &lt; 5)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">II</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> &lt; 5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> &lt; 5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.6%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">III</td>
<td align="center" valign="top" rowspan="1" colspan="1">32 (16%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">32 (17%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (12%)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">IV</td>
<td align="center" valign="top" rowspan="1" colspan="1">24 (12%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (10%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (13%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alcohol, (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (4.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (5.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.6%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Smoking, (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">37 (19%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (20%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 (16%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurological comorbidity, (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 (15%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (8.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (7.8%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Preexisting sensory disturbances, (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">24 (12%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (8.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (7.3%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Prescription within ATC group AT10 (i.e., drugs used in diabetes), (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">55 (28%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">45 (25%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (5.2%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bcpt70022-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="bcpt70022-note-0002"><p>Abbreviation: FIGO, Fédération Internationale de Gynécologie et d'Obstétrique (International Federation of Obstetrics and Gynecologic).</p></div></div></section></section><section id="bcpt70022-sec-0019"><h3 class="pmc_sec_title">3.3. Paclitaxel Treatment Discontinuation</h3>
<p>Among 576 paclitaxel‐treated women, 131 discontinued paclitaxel treatment due to PIPN; 8 of the women had other concurrent causes. Specifically, early paclitaxel discontinuation due to PIPN occurred in 17 of 200 (8.5%) atorvastatin users; 14 of 183 (7.7%) simvastatin users; and 8 of 193 (4.1%) nonusers.</p>
<p>The risk of early paclitaxel discontinuation due to PIPN was not increased among atorvastatin users compared with simvastatin users (adjusted OR 0.80, 95% CI 0.34–1.88; Table <a href="#bcpt70022-tbl-0002" class="usa-link">2</a>). The corresponding adjusted OR for all recorded treatment cycles was 0.87 [95% CI 0.51–1.48]. The exclusion of patients with diabetes and patients with preexisting sensory disturbances primarily reduced the ORs related to PIPN, but the findings remained statistically nonsignificant (Tables <a href="#bcpt70022-supitem-0001" class="usa-link">S3</a>, <a href="#bcpt70022-supitem-0001" class="usa-link">S5</a> and <a href="#bcpt70022-supitem-0001" class="usa-link">S6</a>).</p>
<section class="tw xbox font-sm" id="bcpt70022-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Risk of paclitaxel discontinuation with use of atorvastatin compared with simvastatin and nonuse, respectively, and specified by cause.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th colspan="6" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">Risk of paclitaxel discontinuation with use of atorvastatin compared with simvastatin</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Cause</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Atorvastatin (<em>n</em> = 200)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Simvastatin (<em>n</em> = 183)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Crude OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Adjusted<a href="#bcpt70022-note-0003" class="usa-link">
<sup>a</sup>
</a> OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>‐value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any discontinuation (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 (41.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">61 (33.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.42 (0.94–2.15)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.03 (0.63–1.67)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.917</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any discontinuation (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (17.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (12.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.48 (0.84–2.61)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.15 (0.59–2.25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.688</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54 (27.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">42 (23.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.24 (0.78–1.98)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.87 (0.51–1.48)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.608</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (8.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (7.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.12 (0.54–2.34)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.80 (0.34–1.88)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.609</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Haematological toxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> &lt; 5</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Poor health (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (11.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (8.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.29 (0.66–2.54)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.76 (0.33–1.74)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.519</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Allergic reaction (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (5.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> &lt; 5</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.49 (0.96–12.72)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.02 (0.82–19.67)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.086</td>
</tr>
</tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th colspan="6" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">Risk of paclitaxel discontinuation with use of atorvastatin compared with nonuse</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Cause</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Atorvastatin (<em>n</em> = 200)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Nonuse (<em>n</em> = 193)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Crude OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Adjusted<a href="#bcpt70022-note-0003" class="usa-link">
<sup>a</sup>
</a> OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>‐value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any discontinuation (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 (41.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">65 (33.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.40 (0.93–2.11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.01 (0.61–1.66)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.977</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any discontinuation (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (17.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">26 (13.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.36 (0.79–2.36)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.89 (0.46–1.73)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.736</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54 (27.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (18.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.67 (1.03–2.70)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.24 (0.68–2.25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.487</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (8.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (4.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.15 (0.90–5.10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.24 (0.44–3.53)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.682</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Haematological toxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Poor health (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (11.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (8.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.37 (0.69–2.69)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.41–2.29)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.940</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Allergic reaction (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (5.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (4.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.35 (0.53–3.42)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.07 (0.38–2.97)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.902</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bcpt70022-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="bcpt70022-note-0003">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Adjusted for age, alcohol, smoking, neurological comorbidity and diabetes.</p>
</div></div></section><p>The risk of early paclitaxel discontinuation due to PIPN was increased among atorvastatin users compared with nonusers (adjusted OR 1.24, 95% CI 0.44–3.53; Table <a href="#bcpt70022-tbl-0002" class="usa-link">2</a>), although not statistically significantly. The corresponding adjusted OR for all recorded treatment cycles was 1.24 [95% CI 0.68–2.25].</p>
<p>When patients with breast cancer and patients with gynaecologic cancer were analysed separately with respect to statin use and risk of early paclitaxel discontinuation due to PIPN, the results remained statistically nonsignificant (Table <a href="#bcpt70022-supitem-0001" class="usa-link">S7</a>).</p></section><section id="bcpt70022-sec-0020"><h3 class="pmc_sec_title">3.4. Paclitaxel Treatment Modification</h3>
<p>In our secondary analysis, atorvastatin use was not associated with paclitaxel treatment modification due to PIPN with an adjusted OR of 0.71 [95% CI 0.44–1.15] (Table <a href="#bcpt70022-tbl-0003" class="usa-link">3</a>) and 1.22 [95% CI 0.72–2.06] (Table <a href="#bcpt70022-tbl-0003" class="usa-link">3</a>) when compared with simvastatin use and nonuse, respectively.</p>
<section class="tw xbox font-sm" id="bcpt70022-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Risk of paclitaxel treatment modification with use of atorvastatin compared with simvastatin and nonuse, respectively, and specified by cause.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th colspan="6" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">Risk of paclitaxel treatment modification with use of atorvastatin compared with simvastatin</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Cause</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Atorvastatin (<em>n</em> = 200)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Simvastatin (<em>n</em> = 183)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Crude OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Adjusted<a href="#bcpt70022-note-0004" class="usa-link">
<sup>a</sup>
</a> OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>‐value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any modification (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">123 (61.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">110 (60.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.06 (0.70–1.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.86 (0.53–1.40)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.549</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any modification (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">84 (42.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">81 (44.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.91 (0.61–1.37)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.83 (0.52–1.34)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.449</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">70 (35.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">74 (40.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.79 (0.52–1.20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.71 (0.44–1.15)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.163</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">45 (22.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (24.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.92 (0.57–1.47)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.89 (0.51–1.57)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.694</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Haematological toxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> &lt; 5</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Poor health (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (11.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (8.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.29 (0.66–2.54)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.76 (0.33–1.74)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.519</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Allergic reaction (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (5.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> &lt; 5</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.49 (0.96–12.72)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.02 (0.82–19.67)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.086</td>
</tr>
</tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th colspan="6" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">Risk of paclitaxel treatment modification with use of atorvastatin compared with nonuse</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Cause</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Atorvastatin (<em>n</em> = 200)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Nonuse (<em>n</em> = 193)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Crude OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Adjusted<a href="#bcpt70022-note-0004" class="usa-link">
<sup>a</sup>
</a> OR [95% CI]</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>‐value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any modification (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">123 (61.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">107 (55.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.28 (0.86–1.92)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.00 (0.62–1.62)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.998</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Any modification (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">84 (42.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">69 (35.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.30 (0.87–1.95)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.19 (0.73–1.94)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.481</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">70 (35.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52 (26.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.46 (0.95–2.25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.22 (0.72–2.06)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.456</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Neurotoxicity (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">45 (22.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 (15.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.58 (0.95–2.63)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.50 (0.82–2.77)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.192</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Haematological toxicity (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (2.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Poor health (all)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (11.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (8.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.37 (0.69–2.69)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.41–2.29)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.940</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Allergic reaction (early)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (5.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (4.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.35 (0.53–3.42)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.07 (0.38–2.97)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.902</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bcpt70022-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="bcpt70022-note-0004">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Adjusted for age, alcohol, smoking, neurological comorbidity and diabetes.</p>
</div></div></section><p>After excluding patients with diabetes from the analyses, users of atorvastatin were less than half as likely to experience paclitaxel treatment modification due to PIPN compared with simvastatin users (adjusted OR 0.47, 95% CI 0.26–0.82; Table <a href="#bcpt70022-supitem-0001" class="usa-link">S4</a>).</p></section></section><section id="bcpt70022-sec-0021"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>In our study, the highest concentration of atorvastatin exacerbated paclitaxel neurotoxicity in vitro, but we found no association between atorvastatin use and early paclitaxel discontinuation due to PIPN. Some variation was observed when our clinical observations included all recorded treatment cycles, and the secondary outcomes were analysed; however, all associations remained statistically nonsignificant.</p>
<p>To our knowledge, the evidence for atorvastatin use as a risk factor for PIPN is limited to one study. Stage et al. [<a href="#bcpt70022-bib-0010" class="usa-link" aria-describedby="bcpt70022-bib-0010">10</a>] found that the risk of paclitaxel dose modification due to peripheral neuropathy significantly increased to 7.0‐fold in patients treated with atorvastatin after adjusting for age, body surface area, tumour type, cancer stage, treatment schedule and previous chemotherapy. We found that the risk of peripheral neuropathy among users of atorvastatin increased to 1.2‐fold compared with nonusers of statins. This difference might be caused by several factors. Firstly, the stronger association previously found might be due to residual confounding by diabetes or other potential risk factors for peripheral neuropathy, including smoking. Secondly, phenotyping of PIPN is complicated and challenging, even for prospective clinical studies, with the existing subjective methods. Currently, there is no objective tool to grade PIPN [<a href="#bcpt70022-bib-0023" class="usa-link" aria-describedby="bcpt70022-bib-0023">23</a>]. Thirdly, use of statins has in itself been linked to peripheral neuropathy [<a href="#bcpt70022-bib-0024" class="usa-link" aria-describedby="bcpt70022-bib-0024">24</a>, <a href="#bcpt70022-bib-0025" class="usa-link" aria-describedby="bcpt70022-bib-0025">25</a>], although the evidence is highly inconsistent [<a href="#bcpt70022-bib-0026" class="usa-link" aria-describedby="bcpt70022-bib-0026">26</a>]. Lastly, using register data to identify statin exposure status might have misclassified some individuals, which in turn will have diluted the associations observed.</p>
<p>The major strength of this study is the translational approach that combines in vitro findings with clinical data. Through an interdisciplinary collaboration, we have highlighted that our in vitro findings involving statins and paclitaxel neurotoxicity cannot be detected clinically in our setting. We differentiated iPSCs into human sensory neurons to recapitulate the characteristic morphologic, transcriptional and functional properties of sensory neurons. Compared with SH‐SY5Y‐derived neurons that were previously used to study this drug–drug interaction (DDI), iPSC‐SNs constitute multiple sensory neuron subtypes and express receptors involved in the perception of pain [<a href="#bcpt70022-bib-0013" class="usa-link" aria-describedby="bcpt70022-bib-0013">13</a>]. Furthermore, we included a large patient cohort involving major hospitals spread across all five regions in Denmark. We included an active comparator group (i.e., simvastatin users) to help establish the effects of atorvastatin, and by blinding the review process to statin exposure status, the risk of bias was reduced. Finally, by incorporating early paclitaxel discontinuation due to PIPN as a clinically relevant main endpoint, clearly documented in medical records, we avoided relying on often inadequate recording of PIPN occurrence and severity.</p>
<p>There are many practical challenges in obtaining reliable data on the incidence and extent of PIPN, both retrospectively and prospectively. As previously mentioned, objective measures of different PIPN phenotypes do not exist, and therefore, it is difficult for clinicians to reliably assess the extent of PIPN. Even though grading systems for PIPN exist, they have not been systematically incorporated in clinical practice and rely solely on patient or physician descriptions of symptoms. Consequently, it was not possible to correlate atorvastatin use directly to the degree of PIPN by reviewing medical records. We have recently shown that neurofilament light chain measured in serum (sNFL) is a useful and objective biomarker of PIPN in ovarian cancer patients [<a href="#bcpt70022-bib-0013" class="usa-link" aria-describedby="bcpt70022-bib-0013">13</a>] and as such, sNFL may serve as an tool for phenotyping PIPN in future clinical studies.</p>
<p>A limitation of our in vitro work is that we only focused on pharmacodynamic DDIs, so our results do not account for pharmacokinetic DDIs occurring in the liver. Although genome‐wide association studies have found that genetic variants in <em>ABCB1</em> are associated with an increased risk of PIPN [<a href="#bcpt70022-bib-0027" class="usa-link" aria-describedby="bcpt70022-bib-0027">27</a>], in vitro studies show that clinically relevant concentrations of statins are not able to inhibit CYP2C8, the main drug‐metabolizing enzyme of paclitaxel [<a href="#bcpt70022-bib-0028" class="usa-link" aria-describedby="bcpt70022-bib-0028">28</a>]. Nonetheless, a hepatic‐specific interaction at clinically relevant concentrations cannot be entirely disregarded if P‐gp is involved in hepatic and renal elimination of paclitaxel. Another limitation of our in vitro work is that we only assessed possible interactions between paclitaxel and the parent compounds of the statins. Therefore, the contribution of atorvastatin and simvastatin metabolites in exacerbating neurotoxicity during paclitaxel treatment was not assessed. Additionally, possible DDIs were assessed using a single iPSC donor with an unknown clinical background, and this might limit the generalizability of our in vitro results.</p>
<p>In conclusion, we found no evidence of an increased risk of PIPN requiring paclitaxel treatment adjustment with use of atorvastatin as compared with simvastatin use in a nationwide cohort of paclitaxel‐treated cancer patients. However, our in vitro results showed that the highest concentration of atorvastatin increased paclitaxel neurotoxicity in iPSC‐SNs. The limitations of the clinical study, including register‐based exposure status and reliance on medical records for all outcomes (i.e., phenotyping of PIPN), might have hindered detection of a clinical effect. Therefore, although our findings indicate no increased risk, it would be premature to firmly conclude that atorvastatin does not exacerbate PIPN.</p></section><section id="bcpt70022-sec-0027"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>The study was designed by authors ES, CM, TBS and AP. All clinical data were collected by ES. All cell data were collected by CM. The analyses were carried out by CM, MO and MTE. The first draft was written by ES, CM and AP. and revised for important intellectual content by all authors. The final version of the paper was approved by all authors.</p></section><section id="bcpt70022-sec-0026"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The study was approved by the Danish Health Data Authority (record no. 00004814), Region of Southern Denmark (record no 21/50988), the Danish Patient Safety Authority (record no. 31‐1521‐179), OPEN (ID: OP_1137) and the repository of the University of Southern Denmark (record no 10.900). All hospital departments involved consented to the study's review of medical records. According to Danish law, neither patient consent nor approval from an ethical committee was needed for this study, as it did not involve biological material or patient contact. We performed this study in accordance with the Declaration of Helsinki.</p></section><section id="bcpt70022-sec-0023"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Tore Bjerregaard Stage has given paid lectures for Pfizer and Eisai and done consulting for Pfizer, all unrelated to the present work. Anton Pottegård reports participation in research projects funded by Alcon, Almirall, Astellas, Astra‐Zeneca, Boehringer‐Ingelheim, Novo Nordisk, Servier and LEO Pharma, all regulator‐mandated phase IV‐studies, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the work reported in this paper. The remaining authors report no potential conflicts of interest.</p></section><section id="sec23"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="bcpt70022-supitem-0001"><div class="caption p">
<p>
<strong>Table S1:</strong> Considerations for clinically relevant concentrations used in the cell study.</p>
<p>
<strong>Table S2:</strong> List of gynaeecologic and breast cancer diagnosis codes (International Classification of Diseases, 10th revision).</p>
<p>
<strong>Table S3:</strong> Risk of paclitaxel discontinuation with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with diabetes.</p>
<p>
<strong>Table S4:</strong> Risk of paclitaxel treatment modification with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with diabetes.</p>
<p>
<strong>Table S5:</strong> Risk of paclitaxel discontinuation with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with preexisting sensory disturbances.</p>
<p>
<strong>Table S6:</strong> Risk of paclitaxel treatment modification with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with preexisting sensory disturbances.</p>
<p>
<strong>Table S7:</strong> Risk of paclitaxel discontinuation with use of atorvastatin compared to simvastatin, specified by cause and cancer type.</p>
<p>
<strong>Figure S1:</strong> Example of an image of iPSC‐derived sensory neurons after threshold adjustment and Sholl analysis of a single ganglion. Cells were immunostained for peripherin, and images were obtained. Sholl analysis were performed in ImageJ using an appropriate threshold to visualize the neuronal network. The centre of each ganglion was marked using the straight‐line tool, and the number of axons was then quantified at an appropriate end radius.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11955935/bin/BCPT-136-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">BCPT-136-0-s001.docx</a><sup> (711.5KB, docx) </sup>
</div></div></section></section><section id="bcpt70022-sec-0022" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We acknowledge the oncology departments for assisting in obtaining medical records. We also acknowledge the assistance of OPEN, Odense University Hospital, Region of Southern Denmark. The authors would like to thank Sissel Mogensen for the originally drawn graphical abstract and Mikkel Thy Thomsen for his assistance in adding scale bars to the images of neuronal networks.</p></section><section id="notes1"><section id="bcpt70022-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="bcpt70022-note-0001"><p>
<strong>Funding:</strong> This work was supported by the Danish Cancer Society (Grant R231‐A13918) and Odense University Hospital Fund for Pre‐graduate Stipends (Grant A4941).</p></div></div></section></section><section id="bcpt70022-sec-0025"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The clinical dataset supporting the conclusions of this article is kept at the Danish Health Data Authority (record no. 00004814). The dataset is pseudonymized at the Danish Health Data Authority. The clinical dataset cannot be made public due to GDPR and ethical restrictions. The cell data are available in a separate file.</p></section><section id="bcpt70022-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="bcpt70022-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bcpt70022-bib-0001">
<span class="label">1.</span><cite>
Engvall K., Gréen H., Fredriksson M., and Åvall‐Lundqvist E., “Persistent Neuropathy Among Early‐Stage Breast Cancer Survivors in a Population‐Based Cohort,” British Journal of Cancer
125, no. 3 (2021): 445–457, 10.1038/s41416-021-01429-3.
</cite> [<a href="https://doi.org/10.1038/s41416-021-01429-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8329002/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34017086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Cancer&amp;title=Persistent%20Neuropathy%20Among%20Early%E2%80%90Stage%20Breast%20Cancer%20Survivors%20in%20a%20Population%E2%80%90Based%20Cohort&amp;author=K.%20Engvall&amp;author=H.%20Gr%C3%A9en&amp;author=M.%20Fredriksson&amp;author=E.%20%C3%85vall%E2%80%90Lundqvist&amp;volume=125&amp;issue=3&amp;publication_year=2021&amp;pages=445-457&amp;pmid=34017086&amp;doi=10.1038/s41416-021-01429-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0002">
<span class="label">2.</span><cite>
Park S., Krishnan A., Lin C., Goldstein D., Friedlander M., and Kiernan M., “Mechanisms Underlying Chemotherapy‐Induced Neurotoxicity and the Potential for Neuroprotective Strategies,” CMC
15, no. 29 (2008): 3081–3094, 10.2174/092986708786848569.</cite> [<a href="https://doi.org/10.2174/092986708786848569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19075655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CMC&amp;title=Mechanisms%20Underlying%20Chemotherapy%E2%80%90Induced%20Neurotoxicity%20and%20the%20Potential%20for%20Neuroprotective%20Strategies&amp;author=S.%20Park&amp;author=A.%20Krishnan&amp;author=C.%20Lin&amp;author=D.%20Goldstein&amp;author=M.%20Friedlander&amp;volume=15&amp;issue=29&amp;publication_year=2008&amp;pages=3081-3094&amp;pmid=19075655&amp;doi=10.2174/092986708786848569&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0003">
<span class="label">3.</span><cite>
Hershman D. L., Till C., Wright J. D., et al., “Comorbidities and Risk of Chemotherapy‐Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials,” JCO
34, no. 25 (2016): 3014–3022, 10.1200/JCO.2015.66.2346.</cite> [<a href="https://doi.org/10.1200/JCO.2015.66.2346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5012713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27325863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCO&amp;title=Comorbidities%20and%20Risk%20of%20Chemotherapy%E2%80%90Induced%20Peripheral%20Neuropathy%20Among%20Participants%2065%20Years%20or%20Older%20in%20Southwest%20Oncology%20Group%20Clinical%20Trials&amp;author=D.%20L.%20Hershman&amp;author=C.%20Till&amp;author=J.%20D.%20Wright&amp;volume=34&amp;issue=25&amp;publication_year=2016&amp;pages=3014-3022&amp;pmid=27325863&amp;doi=10.1200/JCO.2015.66.2346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0004">
<span class="label">4.</span><cite>
Sparano J. A., Saphner T., and Davidson N. E., “Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer,” New England Journal of Medicine
358 (2008): 1663–1671.
</cite> [<a href="https://doi.org/10.1056/NEJMoa0707056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2743943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18420499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Weekly%20Paclitaxel%20in%20the%20Adjuvant%20Treatment%20of%20Breast%20Cancer&amp;author=J.%20A.%20Sparano&amp;author=T.%20Saphner&amp;author=N.%20E.%20Davidson&amp;volume=358&amp;publication_year=2008&amp;pages=1663-1671&amp;pmid=18420499&amp;doi=10.1056/NEJMoa0707056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0005">
<span class="label">5.</span><cite>
Pabst L., Velten M., Fischbach C., et al., “Persistent Taxane‐Induced Neuropathy in Elderly Patients Treated for Localized Breast Cancer,” Breast Journal
26, no. 12 (2020): 2376–2382, 10.1111/tbj.14123.
</cite> [<a href="https://doi.org/10.1111/tbj.14123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33307596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Journal&amp;title=Persistent%20Taxane%E2%80%90Induced%20Neuropathy%20in%20Elderly%20Patients%20Treated%20for%20Localized%20Breast%20Cancer&amp;author=L.%20Pabst&amp;author=M.%20Velten&amp;author=C.%20Fischbach&amp;volume=26&amp;issue=12&amp;publication_year=2020&amp;pages=2376-2382&amp;pmid=33307596&amp;doi=10.1111/tbj.14123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0006">
<span class="label">6.</span><cite>
Starobova H. and Vetter I., “Pathophysiology of Chemotherapy‐Induced Peripheral Neuropathy,” Frontiers in Molecular Neuroscience
10 (2017): 174, 10.3389/fnmol.2017.00174.
</cite> [<a href="https://doi.org/10.3389/fnmol.2017.00174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5450696/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28620280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Molecular%20Neuroscience&amp;title=Pathophysiology%20of%20Chemotherapy%E2%80%90Induced%20Peripheral%20Neuropathy&amp;author=H.%20Starobova&amp;author=I.%20Vetter&amp;volume=10&amp;publication_year=2017&amp;pages=174&amp;pmid=28620280&amp;doi=10.3389/fnmol.2017.00174&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0007">
<span class="label">7.</span><cite>
Nielsen S. W., Eckhoff L., Ruhlmann C. H. B., Herrstedt J., and Dalton S. O., “The Prevalence, Distribution and Impact of Peripheral Neuropathy Among Danish Patients With Cancer—A Population‐Based Cross‐Sectional Study,” Acta Oncologica
61, no. 3 (2022): 363–370, 10.1080/0284186X.2021.2007283.
</cite> [<a href="https://doi.org/10.1080/0284186X.2021.2007283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34846991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncologica&amp;title=The%20Prevalence,%20Distribution%20and%20Impact%20of%20Peripheral%20Neuropathy%20Among%20Danish%20Patients%20With%20Cancer%E2%80%94A%20Population%E2%80%90Based%20Cross%E2%80%90Sectional%20Study&amp;author=S.%20W.%20Nielsen&amp;author=L.%20Eckhoff&amp;author=C.%20H.%20B.%20Ruhlmann&amp;author=J.%20Herrstedt&amp;author=S.%20O.%20Dalton&amp;volume=61&amp;issue=3&amp;publication_year=2022&amp;pages=363-370&amp;pmid=34846991&amp;doi=10.1080/0284186X.2021.2007283&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0008">
<span class="label">8.</span><cite>
Mielke S., Sparreboom A., and Mross K., “Peripheral Neuropathy: A Persisting Challenge in Paclitaxel‐Based Regimes,” European Journal of Cancer
42, no. 1 (2006): 24–30, 10.1016/j.ejca.2005.06.030.
</cite> [<a href="https://doi.org/10.1016/j.ejca.2005.06.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16293411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Cancer&amp;title=Peripheral%20Neuropathy:%20A%20Persisting%20Challenge%20in%20Paclitaxel%E2%80%90Based%20Regimes&amp;author=S.%20Mielke&amp;author=A.%20Sparreboom&amp;author=K.%20Mross&amp;volume=42&amp;issue=1&amp;publication_year=2006&amp;pages=24-30&amp;pmid=16293411&amp;doi=10.1016/j.ejca.2005.06.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0009">
<span class="label">9.</span><cite>
Sánchez‐Barroso L., Apellaniz‐Ruiz M., Gutiérrez‐Gutiérrez G., et al., “Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy,” Oncolology
24, no. 8 (2019): e784–e792, 10.1634/theoncologist.2018-0418.</cite> [<a href="https://doi.org/10.1634/theoncologist.2018-0418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6693699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30470691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncolology&amp;title=Concomitant%20Medications%20and%20Risk%20of%20Chemotherapy%E2%80%90Induced%20Peripheral%20Neuropathy&amp;author=L.%20S%C3%A1nchez%E2%80%90Barroso&amp;author=M.%20Apellaniz%E2%80%90Ruiz&amp;author=G.%20Guti%C3%A9rrez%E2%80%90Guti%C3%A9rrez&amp;volume=24&amp;issue=8&amp;publication_year=2019&amp;pages=e784-e792&amp;pmid=30470691&amp;doi=10.1634/theoncologist.2018-0418&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0010">
<span class="label">10.</span><cite>
Stage T. B., Mortensen C., Khalaf S., et al., “P‐Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer,” Clinical Pharmacology and Therapeutics
108, no. 3 (2020): 671–680, 10.1002/cpt.1847.
</cite> [<a href="https://doi.org/10.1002/cpt.1847" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8135112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32275773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20and%20Therapeutics&amp;title=P%E2%80%90Glycoprotein%20Inhibition%20Exacerbates%20Paclitaxel%20Neurotoxicity%20in%20Neurons%20and%20Patients%20With%20Cancer&amp;author=T.%20B.%20Stage&amp;author=C.%20Mortensen&amp;author=S.%20Khalaf&amp;volume=108&amp;issue=3&amp;publication_year=2020&amp;pages=671-680&amp;pmid=32275773&amp;doi=10.1002/cpt.1847&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0011">
<span class="label">11.</span><cite>
Mortensen C., Thomsen M. T., Chua K. C., et al., “Modeling Mechanisms of Chemotherapy‐Induced Peripheral Neuropathy and Chemotherapy Transport Using Induced Pluripotent Stem Cell‐Derived Sensory Neurons,” Neuropharmacology
258 (2024): 110062, 10.1016/j.neuropharm.2024.110062.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2024.110062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38972371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Modeling%20Mechanisms%20of%20Chemotherapy%E2%80%90Induced%20Peripheral%20Neuropathy%20and%20Chemotherapy%20Transport%20Using%20Induced%20Pluripotent%20Stem%20Cell%E2%80%90Derived%20Sensory%20Neurons&amp;author=C.%20Mortensen&amp;author=M.%20T.%20Thomsen&amp;author=K.%20C.%20Chua&amp;volume=258&amp;publication_year=2024&amp;pages=110062&amp;pmid=38972371&amp;doi=10.1016/j.neuropharm.2024.110062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0012">
<span class="label">12.</span><cite>
Tveden‐Nyborg P., Bergmann T. K., Jessen N., Simonsen U., and Lykkesfeldt J., “BCPT 2023 Policy for Experimental and Clinical Studies,” Basic &amp; Clinical Pharmacology &amp; Toxicology
133, no. 4 (2023): 391–396, 10.1111/bcpt.13944.
</cite> [<a href="https://doi.org/10.1111/bcpt.13944" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37732406/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20&amp;%20Clinical%20Pharmacology%20&amp;%20Toxicology&amp;title=BCPT%202023%20Policy%20for%20Experimental%20and%20Clinical%20Studies&amp;author=P.%20Tveden%E2%80%90Nyborg&amp;author=T.%20K.%20Bergmann&amp;author=N.%20Jessen&amp;author=U.%20Simonsen&amp;author=J.%20Lykkesfeldt&amp;volume=133&amp;issue=4&amp;publication_year=2023&amp;pages=391-396&amp;pmid=37732406&amp;doi=10.1111/bcpt.13944&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0013">
<span class="label">13.</span><cite>
Mortensen C., Steffensen K. D., Simonsen E., et al., “Neurofilament Light Chain as a Biomarker of Axonal Damage in Sensory Neurons and Paclitaxel‐Induced Peripheral Neuropathy in Ovarian Cancer Patients,” Pain
164 (2022): 1502–1511, 10.1097/j.pain.0000000000002840.
</cite> [<a href="https://doi.org/10.1097/j.pain.0000000000002840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36508173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;title=Neurofilament%20Light%20Chain%20as%20a%20Biomarker%20of%20Axonal%20Damage%20in%20Sensory%20Neurons%20and%20Paclitaxel%E2%80%90Induced%20Peripheral%20Neuropathy%20in%20Ovarian%20Cancer%20Patients&amp;author=C.%20Mortensen&amp;author=K.%20D.%20Steffensen&amp;author=E.%20Simonsen&amp;volume=164&amp;publication_year=2022&amp;pages=1502-1511&amp;pmid=36508173&amp;doi=10.1097/j.pain.0000000000002840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0014">
<span class="label">14.</span><cite>
Mortensen C., Andersen N. E., and Stage T. B., “Bridging the Translational Gap in Chemotherapy‐Induced Peripheral Neuropathy With iPSC‐Based Modeling,” Cancers (Basel)
14, no. 16 (2022): 3939, 10.3390/cancers14163939.
</cite> [<a href="https://doi.org/10.3390/cancers14163939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9406154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36010931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Bridging%20the%20Translational%20Gap%20in%20Chemotherapy%E2%80%90Induced%20Peripheral%20Neuropathy%20With%20iPSC%E2%80%90Based%20Modeling&amp;author=C.%20Mortensen&amp;author=N.%20E.%20Andersen&amp;author=T.%20B.%20Stage&amp;volume=14&amp;issue=16&amp;publication_year=2022&amp;pages=3939&amp;pmid=36010931&amp;doi=10.3390/cancers14163939&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0015">
<span class="label">15.</span><cite>
Stage T. B., Bergmann T. K., and Kroetz D. L., “Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review,” Clinical Pharmacokinetics
57, no. 1 (2018): 7–19, 10.1007/s40262-017-0563-z.
</cite> [<a href="https://doi.org/10.1007/s40262-017-0563-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8572663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28612269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacokinetics&amp;title=Clinical%20Pharmacokinetics%20of%20Paclitaxel%20Monotherapy:%20An%20Updated%20Literature%20Review&amp;author=T.%20B.%20Stage&amp;author=T.%20K.%20Bergmann&amp;author=D.%20L.%20Kroetz&amp;volume=57&amp;issue=1&amp;publication_year=2018&amp;pages=7-19&amp;pmid=28612269&amp;doi=10.1007/s40262-017-0563-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0016">
<span class="label">16.</span><cite>
Shin G. J., “Towards a Mechanistic Understanding of Axon Transport and Endocytic Changes Underlying Paclitaxel‐Induced Peripheral Neuropathy,” Experimental Neurology
359 (2023): 114258, 10.1016/j.expneurol.2022.114258.
</cite> [<a href="https://doi.org/10.1016/j.expneurol.2022.114258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36279934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20Neurology&amp;title=Towards%20a%20Mechanistic%20Understanding%20of%20Axon%20Transport%20and%20Endocytic%20Changes%20Underlying%20Paclitaxel%E2%80%90Induced%20Peripheral%20Neuropathy&amp;author=G.%20J.%20Shin&amp;volume=359&amp;publication_year=2023&amp;pages=114258&amp;pmid=36279934&amp;doi=10.1016/j.expneurol.2022.114258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0017">
<span class="label">17.</span><cite>
Sundhedsdatastyrelsen—Statistikker. Accessed November 4, 2022, <a href="https://medstat.dk/en" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://medstat.dk/en</a>.</cite>
</li>
<li id="bcpt70022-bib-0018">
<span class="label">18.</span><cite>
Schmidt M., Schmidt S. A. J., Sandegaard J. L., Ehrenstein V., Pedersen L., and Sørensen H. T., “The Danish National Patient Registry: A Review of Content, Data Quality, and Research Potential,” Clinical Epidemiology
7 (2015): 449–490, 10.2147/CLEP.S91125.
</cite> [<a href="https://doi.org/10.2147/CLEP.S91125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4655913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26604824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Epidemiology&amp;title=The%20Danish%20National%20Patient%20Registry:%20A%20Review%20of%20Content,%20Data%20Quality,%20and%20Research%20Potential&amp;author=M.%20Schmidt&amp;author=S.%20A.%20J.%20Schmidt&amp;author=J.%20L.%20Sandegaard&amp;author=V.%20Ehrenstein&amp;author=L.%20Pedersen&amp;volume=7&amp;publication_year=2015&amp;pages=449-490&amp;pmid=26604824&amp;doi=10.2147/CLEP.S91125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0019">
<span class="label">19.</span><cite>
Schmidt M., Pedersen L., and Sørensen H. T., “The Danish Civil Registration System as a Tool in Epidemiology,” European Journal of Epidemiology
29, no. 8 (2014): 541–549, 10.1007/s10654-014-9930-3.
</cite> [<a href="https://doi.org/10.1007/s10654-014-9930-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24965263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Epidemiology&amp;title=The%20Danish%20Civil%20Registration%20System%20as%20a%20Tool%20in%20Epidemiology&amp;author=M.%20Schmidt&amp;author=L.%20Pedersen&amp;author=H.%20T.%20S%C3%B8rensen&amp;volume=29&amp;issue=8&amp;publication_year=2014&amp;pages=541-549&amp;pmid=24965263&amp;doi=10.1007/s10654-014-9930-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0020">
<span class="label">20.</span><cite>
Rasmussen L., Valentin J., Gesser K. M., Hallas J., and Pottegård A., “Validity of the Prescriber Information in the Danish National Prescription Registry,” Basic &amp; Clinical Pharmacology &amp; Toxicology
119, no. 4 (2016): 376–380, 10.1111/bcpt.12610.
</cite> [<a href="https://doi.org/10.1111/bcpt.12610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27098169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20&amp;%20Clinical%20Pharmacology%20&amp;%20Toxicology&amp;title=Validity%20of%20the%20Prescriber%20Information%20in%20the%20Danish%20National%20Prescription%20Registry&amp;author=L.%20Rasmussen&amp;author=J.%20Valentin&amp;author=K.%20M.%20Gesser&amp;author=J.%20Hallas&amp;author=A.%20Potteg%C3%A5rd&amp;volume=119&amp;issue=4&amp;publication_year=2016&amp;pages=376-380&amp;pmid=27098169&amp;doi=10.1111/bcpt.12610&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0021">
<span class="label">21.</span><cite>
Pottegård A., Schmidt S. A. J., Wallach‐Kildemoes H., Sørensen H. T., Hallas J., and Schmidt M., “Data Resource Profile: The Danish National Prescription Registry,” International Journal of Epidemiology
46, no. 3 (2017): 798–798f, 10.1093/ije/dyw213.
</cite> [<a href="https://doi.org/10.1093/ije/dyw213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5837522/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27789670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Epidemiology&amp;title=Data%20Resource%20Profile:%20The%20Danish%20National%20Prescription%20Registry&amp;author=A.%20Potteg%C3%A5rd&amp;author=S.%20A.%20J.%20Schmidt&amp;author=H.%20Wallach%E2%80%90Kildemoes&amp;author=H.%20T.%20S%C3%B8rensen&amp;author=J.%20Hallas&amp;volume=46&amp;issue=3&amp;publication_year=2017&amp;pages=798-798f&amp;pmid=27789670&amp;doi=10.1093/ije/dyw213&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0022">
<span class="label">22.</span><cite>
Harris P. A., Taylor R., Thielke R., Payne J., Gonzalez N., and Conde J. G., “Research Electronic Data Capture (REDCap)—A Metadata‐Driven Methodology and Workflow Process for Providing Translational Research Informatics Support,” Journal of Biomedical Informatics
42 (2009): 377–381.
</cite> [<a href="https://doi.org/10.1016/j.jbi.2008.08.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2700030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18929686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biomedical%20Informatics&amp;title=Research%20Electronic%20Data%20Capture%20(REDCap)%E2%80%94A%20Metadata%E2%80%90Driven%20Methodology%20and%20Workflow%20Process%20for%20Providing%20Translational%20Research%20Informatics%20Support&amp;author=P.%20A.%20Harris&amp;author=R.%20Taylor&amp;author=R.%20Thielke&amp;author=J.%20Payne&amp;author=N.%20Gonzalez&amp;volume=42&amp;publication_year=2009&amp;pages=377-381&amp;pmid=18929686&amp;doi=10.1016/j.jbi.2008.08.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0023">
<span class="label">23.</span><cite>
Chan A., Hertz D. L., Morales M., et al., “Biological Predictors of Chemotherapy‐Induced Peripheral Neuropathy (CIPN): MASCC Neurological Complications Working Group Overview,” Support Care Cancer
27, no. 10 (2019): 3729–3737, 10.1007/s00520-019-04987-8.
</cite> [<a href="https://doi.org/10.1007/s00520-019-04987-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6728179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31363906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Support%20Care%20Cancer&amp;title=Biological%20Predictors%20of%20Chemotherapy%E2%80%90Induced%20Peripheral%20Neuropathy%20(CIPN):%20MASCC%20Neurological%20Complications%20Working%20Group%20Overview&amp;author=A.%20Chan&amp;author=D.%20L.%20Hertz&amp;author=M.%20Morales&amp;volume=27&amp;issue=10&amp;publication_year=2019&amp;pages=3729-3737&amp;pmid=31363906&amp;doi=10.1007/s00520-019-04987-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0024">
<span class="label">24.</span><cite>
Gaist D., Jeppesen U., Andersen M., García Rodríguez L. A., Hallas J., and Sindrup S. H., “Statins and Risk of Polyneuropathy: A Case‐Control Study,” Neurology
58, no. 9 (2002): 1333–1337, 10.1212/wnl.58.9.1333.
</cite> [<a href="https://doi.org/10.1212/wnl.58.9.1333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12011277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Statins%20and%20Risk%20of%20Polyneuropathy:%20A%20Case%E2%80%90Control%20Study&amp;author=D.%20Gaist&amp;author=U.%20Jeppesen&amp;author=M.%20Andersen&amp;author=L.%20A.%20Garc%C3%ADa%20Rodr%C3%ADguez&amp;author=J.%20Hallas&amp;volume=58&amp;issue=9&amp;publication_year=2002&amp;pages=1333-1337&amp;pmid=12011277&amp;doi=10.1212/wnl.58.9.1333&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0025">
<span class="label">25.</span><cite>
Svendsen T. d. K., Krøigård T., Wirenfeldt M., et al., “Statin Use and Peripheral Nerve Function—A Prospective Follow‐Up Study,” Basic &amp; Clinical Pharmacology &amp; Toxicology
126, no. 3 (2020): 203–211, 10.1111/bcpt.13320.
</cite> [<a href="https://doi.org/10.1111/bcpt.13320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31505101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20&amp;%20Clinical%20Pharmacology%20&amp;%20Toxicology&amp;title=Statin%20Use%20and%20Peripheral%20Nerve%20Function%E2%80%94A%20Prospective%20Follow%E2%80%90Up%20Study&amp;author=T.%20d.%20K.%20Svendsen&amp;author=T.%20Kr%C3%B8ig%C3%A5rd&amp;author=M.%20Wirenfeldt&amp;volume=126&amp;issue=3&amp;publication_year=2020&amp;pages=203-211&amp;pmid=31505101&amp;doi=10.1111/bcpt.13320&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0026">
<span class="label">26.</span><cite>
Svendsen T. d. K., Nørregaard Hansen P., García Rodríguez L. A., et al., “Statins and Polyneuropathy Revisited: Case‐Control Study in Denmark, 1999–2013: Statins and Polyneuropathy Revisited,” British Journal of Clinical Pharmacology
83, no. 9 (2017): 2087–2095, 10.1111/bcp.13298.
</cite> [<a href="https://doi.org/10.1111/bcp.13298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5555863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28370351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=Statins%20and%20Polyneuropathy%20Revisited:%20Case%E2%80%90Control%20Study%20in%20Denmark,%201999%E2%80%932013:%20Statins%20and%20Polyneuropathy%20Revisited&amp;author=T.%20d.%20K.%20Svendsen&amp;author=P.%20N%C3%B8rregaard%20Hansen&amp;author=L.%20A.%20Garc%C3%ADa%20Rodr%C3%ADguez&amp;volume=83&amp;issue=9&amp;publication_year=2017&amp;pages=2087-2095&amp;pmid=28370351&amp;doi=10.1111/bcp.13298&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0027">
<span class="label">27.</span><cite>
Tanabe Y., Shimizu C., Hamada A., et al., “Paclitaxel‐Induced Sensory Peripheral Neuropathy Is Associated With an ABCB1 Single Nucleotide Polymorphism and Older Age in Japanese,” Cancer Chemotherapy and Pharmacology
79, no. 6 (2017): 1179–1186, 10.1007/s00280-017-3314-9.
</cite> [<a href="https://doi.org/10.1007/s00280-017-3314-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28447211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Chemotherapy%20and%20Pharmacology&amp;title=Paclitaxel%E2%80%90Induced%20Sensory%20Peripheral%20Neuropathy%20Is%20Associated%20With%20an%20ABCB1%20Single%20Nucleotide%20Polymorphism%20and%20Older%20Age%20in%20Japanese&amp;author=Y.%20Tanabe&amp;author=C.%20Shimizu&amp;author=A.%20Hamada&amp;volume=79&amp;issue=6&amp;publication_year=2017&amp;pages=1179-1186&amp;pmid=28447211&amp;doi=10.1007/s00280-017-3314-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70022-bib-0028">
<span class="label">28.</span><cite>
Tornio A., Pasanen M. K., Laitila J., Neuvonen P. J., and Backman J. T., “Comparison of 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A (HMG‐CoA) Reductase Inhibitors (Statins) as Inhibitors of Cytochrome P450 2C8,” Basic &amp; Clinical Pharmacology &amp; Toxicology
97, no. 2 (2005): 104–108, 10.1111/j.1742-7843.2005.pto_134.x.
</cite> [<a href="https://doi.org/10.1111/j.1742-7843.2005.pto_134.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15998357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20&amp;%20Clinical%20Pharmacology%20&amp;%20Toxicology&amp;title=Comparison%20of%203%E2%80%90Hydroxy%E2%80%903%E2%80%90Methylglutaryl%20Coenzyme%20A%20(HMG%E2%80%90CoA)%20Reductase%20Inhibitors%20(Statins)%20as%20Inhibitors%20of%20Cytochrome%20P450%202C8&amp;author=A.%20Tornio&amp;author=M.%20K.%20Pasanen&amp;author=J.%20Laitila&amp;author=P.%20J.%20Neuvonen&amp;author=J.%20T.%20Backman&amp;volume=97&amp;issue=2&amp;publication_year=2005&amp;pages=104-108&amp;pmid=15998357&amp;doi=10.1111/j.1742-7843.2005.pto_134.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<p>
<strong>Table S1:</strong> Considerations for clinically relevant concentrations used in the cell study.</p>
<p>
<strong>Table S2:</strong> List of gynaeecologic and breast cancer diagnosis codes (International Classification of Diseases, 10th revision).</p>
<p>
<strong>Table S3:</strong> Risk of paclitaxel discontinuation with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with diabetes.</p>
<p>
<strong>Table S4:</strong> Risk of paclitaxel treatment modification with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with diabetes.</p>
<p>
<strong>Table S5:</strong> Risk of paclitaxel discontinuation with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with preexisting sensory disturbances.</p>
<p>
<strong>Table S6:</strong> Risk of paclitaxel treatment modification with use of atorvastatin compared to simvastatin and non‐use, respectively, specified by cause and excluding patients with preexisting sensory disturbances.</p>
<p>
<strong>Table S7:</strong> Risk of paclitaxel discontinuation with use of atorvastatin compared to simvastatin, specified by cause and cancer type.</p>
<p>
<strong>Figure S1:</strong> Example of an image of iPSC‐derived sensory neurons after threshold adjustment and Sholl analysis of a single ganglion. Cells were immunostained for peripherin, and images were obtained. Sholl analysis were performed in ImageJ using an appropriate threshold to visualize the neuronal network. The centre of each ganglion was marked using the straight‐line tool, and the number of axons was then quantified at an appropriate end radius.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11955935/bin/BCPT-136-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">BCPT-136-0-s001.docx</a><sup> (711.5KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The clinical dataset supporting the conclusions of this article is kept at the Danish Health Data Authority (record no. 00004814). The dataset is pseudonymized at the Danish Health Data Authority. The clinical dataset cannot be made public due to GDPR and ethical restrictions. The cell data are available in a separate file.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Basic &amp; Clinical Pharmacology &amp; Toxicology are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/bcpt.70022"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/BCPT-136-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11955935/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11955935/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11955935%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955935/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11955935/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11955935/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40143680/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11955935/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40143680/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11955935/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11955935/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="PLvYDNtfXMk1e7aBEj61RWLekuW6oF7FlqjSn1X0tJUzDtWxwLVjUQiGHT1XYelR">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
